|Number of pages||3|
|State||Published - 2 Mar 2019|
Bibliographical noteFunding Information:
SA reports grants from Akebia Therapeutics, GlaxoSmithKline, and KBP Biosciences, outside the submitted work, and is supported by the Chief Scientist Office, Ministry of Health, Israel (grant number 3-00000-9895), and the Harvey and Gloria Kaylie Foundation. MK reports grants from the National Institutes of Health and the University of Michigan during the conduct of the study, grants from Boehringer Ingelheim, Gilead, Lilly, Moderna Therapeutics, Novo Nordisk, Janssen, and AstraZeneca, outside the area of work commented on here, and gifts in support of NEPTUNE from Nephcure Kidney International and Retrophin. KLS reports personal fees from Elsevier, outside the submitted work, and receives support from the Israel Science Foundation (grant number 182/15), the Ernest and Bonnie Beutler Family Foundation, and the Harvey and Gloria Kaylie Foundation. TB declares no competing interests.